[Clinical study of a new cephalosporin, ceftriaxone (Rocefin Roche) in bronchopneumonia in children].
Ceftriaxone (Ro-13-9904) is a broad spectrum cephalosporin with a very long plasma half-life: about 8 h. We administered Ceftriaxone to 9 children suffering from bronchopneumonia. The clinical, X-ray and biochemical response were favourable in all cases.
D000293:Adolescent; D001996:Bronchopneumonia / Q000188:drug therapy*; D002439:Cefotaxime / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use; D002443:Ceftriaxone; D002648:Child; D002675:Child, Preschool; D005260:Female; D006207:Half-Life; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male
D002443:Ceftriaxone; D002439:Cefotaxime
Studio clinico di una nuova cefalosporina, il ceftriaxone (Rocefin Roche), nelle broncopolmoniti in eta' infantile.